ST. LOUIS, June 7 /PRNewswire/ -- Mallinckrodt Brand Pharmaceuticals today announced that it is providing a new pain management drug, called Magnacet(TM) (oxycodone HCl /acetaminophen tablets CII). Magnacet is the only available Oxycodone product coupled with 400mg of acetaminophen, a unique dosage that gives physicians flexibility in treating patients with moderate to moderately severe pain.
Magnacet is indicated for the relief of moderate to moderately severe pain. The most frequently observed adverse reactions include lightheadedness, dizziness, sedation, nausea and vomiting. Oxycodone can produce drug dependence of the morphine-type and, therefore, has the potential for being abused.
"Mallinckrodt Brands is committed to offering additional treatment options that help healthcare providers improve patient care," says Marco Polizzi, executive business director for Mallinckrodt Brand Pharmaceuticals, a unit of Tyco Healthcare/Mallinckrodt. "Magnacet is an example of our efforts to provide proven molecules in unique combinations and strengths in an area such as pain, where it is important that medical professionals are able to tailor treatments for specific needs of patients."
According to Wolters Kluwer Health data, more than 200 million prescriptions were written in the pain market in 2006, representing a 9 percent increase from the previous year. The U.S. Food and Drug Administration (FDA) approved Magnacet in May 2006. The 400mg dose of acetaminophen provides another option for physicians seeking additional dosing flexibility in treating patients with moderate to moderately severe pain.
Magnacet is available in 2.5/400, 5/400, 7.5/400, and 10/400mg tablets through wholesalers and pharmacies in the United States. For more information, including the full prescribing information, please call Mallinckrodt at 1-888-744-1414.
About Mallinckrodt Pharmaceuticals Brands
Mallinckrodt Pharmaceuticals Brands division is dedicated to providing quality pharmaceutical products to help healthcare professionals enhance patient care. The organization consists of over 120 sales and marketing personnel in the continental United States and is engaged in the promotion of a broad range of medications focused on sleep, depression, palliative care, pain management and other areas of the Central Nervous System. For more information, visit http://www.pharmaceuticals.mallinckrodt.com/brand or http://www.tycohealthcare.com.
About Tyco Healthcare/Mallinckrodt
Tyco Healthcare's Mallinckrodt division offers a diverse line of imaging and pharmaceutical products that diagnose disease and relieve pain. As a major business segment of Tyco International Ltd., Tyco Healthcare manufactures, distributes and services an extensive product line including disposable medical supplies, monitoring equipment, innovative wound closure products, advanced surgical devices, medical instruments and bulk analgesic pharmaceuticals. With industry-leading brand names such as Autosuture, Kendall, Mallinckrodt, Nellcor, Puritan Bennett, Syneture and Valleylab, Tyco Healthcare products are found in virtually every healthcare setting.
Trademarks are owned by Mallinckrodt Inc.
Mallinckrodt Inc.CONTACT: JoAnna Schooler, Media Relations, Tyco Healthcare Mallinckrodt,+1-314-654-3543, joanna.schooler@tycohealthcare.com
Web site: http://www.mallinckrodt.com/
